Literature DB >> 25339054

Breast cancer risk factors in women participating in a breast screening program: a study on 11,850 Iranian females.

Mojtaba Sepandi1, Majid Akrami, Hamidreza Tabatabaee, Abdolreza Rajaeefard, Sedigheh Tahmasebi, Kambiz Ahmadi Angali, Abbas Rezaianzadeh, Abdolrasoul Talei.   

Abstract

The incidence rate of breast cancer in developed countries is almost three-fold higher than in developing countries. Iran has had one of the lowest incidence rates for breast cancer in the world, but during the recent decades a marked increase has been seen. The purpose of this study was to investigate some established risk factors of breast cancer in Iranian women. A study of 11,850 women participating in abreast screening program was conducted. The 197 women diagnosed with breast cancer and 11,653 healthy women were compared. Logistic regression was performed to investigate associations of reproductive and anthropometric factors with breast cancer risk. Family history of breast cancer (OR=1.94 , 95%CI=1.35-2.78), occupation (OR= 1.65,95%CI=1.20- 2.25), education level (OR=0.50,95%CI=0.28-0.91), parity (OR=0.27, 95%CI=0.12-0.59), menopausal status (OR=3.15, 95%CI=2.35-4.21), age at menarche (OR=0.33, 95%CI=0.15-0.70), and age at the first pregnancy (OR=4.10 , 95%CI=1.13-14.77) were related to the risk of breast cancer. Decrease in parity may to some extent explain the rising trend of incidence of breast cancer incidence in Iranian women.

Entities:  

Mesh:

Year:  2014        PMID: 25339054     DOI: 10.7314/apjcp.2014.15.19.8499

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Breast Cancer Incidence Trends in Isfahan Province Compared with those in England over the Period 2001-2013.

Authors:  Marziyeh H Ainvand; Najmeh Shakibaei; Zahra Ravankhah; Ghasem Yadegarfar
Journal:  Int J Prev Med       Date:  2021-05-27

2.  The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis.

Authors:  Ali Soroush; Negin Farshchian; Saeid Komasi; Neda Izadi; Nasrin Amirifard; Afshar Shahmohammadi
Journal:  J Cancer Prev       Date:  2016-12-30

3.  Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study.

Authors:  Augustin Balekouzou; Ping Yin; Henok Kessete Afewerky; Cavin Bekolo; Christian Maucler Pamatika; Sylvain Wilfrid Nambei; Marceline Djeintote; Antoine Doui Doumgba; Christian Diamont Mossoro-Kpinde; Chang Shu; Minghui Yin; Zhen Fu; Tingting Qing; Mingming Yan; Jianyuan Zhang; Shaojun Chen; Hongyu Li; Zhongyu Xu; Boniface Koffi
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

4.  Risk Factors Associated with Breast Cancer among Women in Addis Ababa, Ethiopia: Unmatched Case-Control Study.

Authors:  Lidia Tolessa; Endalew Gemechu Sendo; Negalign Getahun Dinegde; Assefa Desalew
Journal:  Int J Womens Health       Date:  2021-01-18

Review 5.  Menstrual and Reproductive Factors and Risk of Breast Cancer in Iranian Female Population: A Systematic Review and Meta-Analysis.

Authors:  Elham Manouchehri; Ali Taghipour; Vahid Ghavami; Fatemeh Homaei Shandiz; Abbas Ebadi; Robab Latifnejad Roudsari
Journal:  Int J Prev Med       Date:  2022-02-23

6.  Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014.

Authors:  Mohammad Esmaeil Akbari; Soheila Sayad; Saed Sayad; Maryam Khayamzadeh; Leila Shojaee; Zeynab Shormeji; Mojtaba Amiri
Journal:  Int J Breast Cancer       Date:  2017-11-01

7.  Knowledge, Attitudes and Practices Regarding Breast Cancer amongst Lebanese Females in Beirut

Authors:  Margueritta El Asmar; Amer Bechnak; Johny Fares; Dana Al Oweini; Ahmad Alrazim; Adnan El Achkar; Hani Tamim
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

8.  Medullary Breast Carcinoma and Invasive Ductal Carcinoma: A Review Study.

Authors:  Vahid Zangouri; Majid Akrami; Sedigheh Tahmasebi; Abdolrasoul Talei; Ali Ghaeini Hesarooeih
Journal:  Iran J Med Sci       Date:  2018-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.